全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Tratamiento adyuvante en el cáncer de mama operable

DOI: 10.4321/S0212-71992008000100010

Keywords: adjuvant chemotherapy, breast cancer, disease-free survival, hormonotherapy.

Full-Text   Cite this paper   Add to My Lib

Abstract:

breast cancer(bc) is the most frequent neoplasm in women of the west countries. the treatment of bc is very complex, and include the combination of surgery, chemotherapy, radiotherapy, hormonetherapy and immunotherapy. surgery is the gold standard in the radical treatment of bc. anthracyclines and taxanes are very important in the adjuvant treatment of bc. these drugs have shown an increased disease-free-survival and overall survival in several studies. tamoxifen has been the gold standard adjuvant hormonetherapy for the treatment of postmenopausal women with hormone-receptor-positive early bc for many years, but the third-generation aromatase inhibitors (letrozole, anastrozole, and exemestane) are now recommended as the preferred therapy. trastuzumab in combination with adjuvant chemotherapy has changed the natural history of early her-2 positive bc. new drugs are under investigation in the treatment of bc.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413